Prestige Consumer Healthcare PBH
NYSE PBH
$51.31 +0.79 (+1.56%)
At close: Aug 21, 2026 · 4:00 PM EDT

Prestige Consumer Healthcare (PBH) Amortization of Deferred Charges (2010 - 2025)

Prestige Consumer Healthcare (PBH) posted quarterly Amortization of Deferred Charges of $452000.0 for Q4 2025, up 4.15% year-over-year from $434000.0 in Q4 2024, and up 1.12% quarter-over-quarter from $447000.0 in Q3 2025.

Prestige Consumer Healthcare (PBH) Amortization of Deferred Charges (2010 - 2025) Analysis & Trends

Prestige Consumer Healthcare's Amortization of Deferred Charges history runs 16 years deep, the most recent figure standing at $452000.0 for Q4 2025.

  • In Q4 2025, Amortization of Deferred Charges rose 4.15% year-over-year to $452000.0; the TTM figure through Dec 2025 stood at $1.8 million (down 37.14% YoY), while the FY2025 annual figure was $1.8 million, down 66.53% from the prior year.
  • Amortization of Deferred Charges for Q4 2025 stood at $452000.0, up from $447000.0 in the prior quarter.
  • The five-year high for Amortization of Deferred Charges was $1.8 million in Q1 2023, with the low at $428000.0 in Q3 2024.
  • The 5-year median for Amortization of Deferred Charges is $821500.0 (2022), against an average of $916950.0.
  • The sharpest annual moves came in 2021 and 2025: Amortization of Deferred Charges jumped 111.37% in 2021, then sank 71.07% in 2025.
  • Prestige Consumer Healthcare's Amortization of Deferred Charges stood at $1.4 million in 2021, then tumbled by 40.77% to $815000.0 in 2022, then jumped by 74.72% to $1.4 million in 2023, then plunged by 69.52% to $434000.0 in 2024, then advanced by 4.15% to $452000.0 in 2025.
  • Business Quant data shows PBH's Amortization of Deferred Charges at $452000.0 in Q4 2025, $447000.0 in Q3 2025, and $442000.0 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 44.51 Bn 43.55 Bn -
2 Teva Pharmaceutical Industries 43.52 Bn 39.86 Bn 2.15 Bn
3 Zoetis 32.43 Bn 30.75 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn
5 United Therapeutics 21.87 Bn 19.21 Bn 683.80 Mn
6 Viatris 18.98 Bn 18.09 Bn 1.46 Bn
7 Neurocrine Biosciences 15.43 Bn 15.04 Bn 935.80 Mn
8 Elanco Animal Health 12.02 Bn 11.49 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.14 Bn 9.98 Bn -
10 Prestige Consumer Healthcare 2.46 Bn 2.39 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2025 452,000.00
Dec 31, 2025 452,000.00
Sep 30, 2025 447,000.00
Sep 30, 2025 447,000.00
Jun 30, 2025 442,000.00
Jun 30, 2025 442,000.00
Mar 31, 2025 438,000.00
Mar 31, 2025 438,000.00
Dec 31, 2024 434,000.00
Dec 31, 2024 434,000.00
Sep 30, 2024 428,000.00
Sep 30, 2024 428,000.00
Jun 30, 2024 454,000.00
Jun 30, 2024 454,000.00
Mar 31, 2024 1.51 Mn
Mar 31, 2024 1.51 Mn
Dec 31, 2023 1.42 Mn
Dec 31, 2023 1.42 Mn
Sep 30, 2023 1.32 Mn
Sep 30, 2023 1.32 Mn